Montreal Children's Hospital, McGill University Health Center
Biological therapies are increasingly used for treatment of malignancies, autoimmunity, and inflammatory diseases involving many different organ systems. It is estimated thatwithin the next 5 years at least 1/5 patients will recieve biological therapies. The effects of these drugs on immune functions and the intermediate and long-term potetntial for immuncompromise are now beginning to be appreciated.
Every physician,with patients in their practice using biologic therapies, needs to be aware of the potential for serious adverse complications associated with these therapies. In this talk we will highlight the areas of concern and discuss proactive patient managment strategies.
As a result of attending this session, participants will be able to:
08:30 - 10:35
|Plenary - 5||Secondary immunodeficiency with biologic therapies: What every doctor should know||recording scheduled|
11:00 - 12:00
|Managing food allergies in kids - Christine McCusker||Managing food allergies in kids||recording scheduled|